A股流感疫苗板块持续走强,达安基因、华兰疫苗、之江生物涨停
Mei Ri Jing Ji Xin Wen·2026-01-26 02:13

Group 1 - The A-share influenza vaccine sector is experiencing a strong performance, with companies such as Da'an Gene, Hualan Biological Engineering, and Zhijiang Biological reaching their daily limit up [1] - Yongshun Biological has seen an increase of over 10%, indicating positive market sentiment towards the sector [1] - Other companies in the sector, including Dongfang Biological, Biological Shares, Zhongsheng Pharmaceutical, Yiling Pharmaceutical, and Rhine Biological, are also witnessing gains [1]

LIFERIVER-A股流感疫苗板块持续走强,达安基因、华兰疫苗、之江生物涨停 - Reportify